For immediate release |
3 September 2012 |
Futura Medical plc
("Futura" or "the Company")
TR-1: Notification of major interest in shares
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
|
|||||||||||||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Futura Medical |
|
||||||||||||||||
2. Reason for the notification (please tick the appropriate box or boxes) |
|
|||||||||||||||||
An acquisition or disposal of voting rights |
|
|
||||||||||||||||
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|
||||||||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|
||||||||||||||||
An event changing the breakdown of voting rights |
|
|
||||||||||||||||
Other (please specify): Transfer into Nominees |
x |
|
||||||||||||||||
3. Full name of person(s) subject to the notification obligation: |
Investec Wealth & Investment Limited |
|
||||||||||||||||
4. Full name of shareholder(s) (if different from 3.): |
|
|
||||||||||||||||
5. Date of the transaction and date on which the threshold is crossed or reached if different: |
28th August 2012 |
|
||||||||||||||||
6. Date on which issuer notified: |
3rd September 2012 |
|
||||||||||||||||
7. Threshold(s) that is/are crossed: |
4% |
|
||||||||||||||||
|
|
|
||||||||||||||||
8.Notified details: Nominee holdings |
||||||||||||||||||
A: Voting rights attached to shares |
||||||||||||||||||
Class/type of Shares
if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
||||||||||||||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights |
||||||||||||||
Direct |
Direct |
Indirect |
Direct |
Indirect |
||||||||||||||
3327847 |
1,863,240 |
1,863,240 |
|
|
3,018,485 |
|
4.09% |
|||||||||||
|
|
|
|
|
|
|
|
|||||||||||
B: Financial Instruments |
||||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||||
Type of financial instrument |
Expiration date |
Exercise/ Conversion Period/ Date |
Number of voting rights that may be acquired if the instrument is exercised/ converted |
% of voting rights |
||||||||||||||
|
|
|
|
|
||||||||||||||
|
|
|
|
|
||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
||||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||||
Type of financial instrument |
Exercise price |
Expiration Date |
Exercise/ Conversion period |
Number of voting rights instrument refers to |
% of voting rights |
|||||||||||||
|
|
|
|
|
Nominal |
Delta |
||||||||||||
|
|
|||||||||||||||||
|
||||||||||||||||||
Total (A+B+C) |
||||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||||
3,018,485 |
4.09% |
|||||||||||||||||
|
|
|||||||||||||||||
Proxy Voting: |
|
|||||||||||||||||
10. Name of the proxy holder: |
N/A |
|||||||||||||||||
11. Number of voting rights proxy holder will cease to hold: |
N/A |
|||||||||||||||||
12. Date on which proxy holder will cease to hold voting rights: |
N/A |
|||||||||||||||||
|
|
|||||||||||||||||
13. Additional information: |
|
|||||||||||||||||
14. Contact name: |
Phil Beardwell Chartered FCSI Senior Compliance Manager |
|||||||||||||||||
15. Contact telephone number: |
020 7597 1356 |
|||||||||||||||||